Working… Menu

CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03168256
Recruitment Status : Recruiting
First Posted : May 30, 2017
Last Update Posted : June 8, 2021
Information provided by (Responsible Party):
Can-Fite BioPharma

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 15, 2021
Estimated Study Completion Date : April 15, 2022